Drug manufacturer AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals.
AbbVie has not yet responded to a request for comment about the changes. Non-hospital covered entities continue to be exempt from AbbVie’s pricing restrictions.
Drug manufacturer AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals. AbbVie has not yet responded to a request for comment about the changes. Non-hospital covered entities continue to be exempt from AbbVie’s pricing restrictions. Drug manufacturers […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.